SmartTarget® technology pinpoints biopsies to detect prostate cancer

6 December 2018

Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting biopsies and improve prostate cancer detection.

A team of engineers and medical researchers found that the technology enabled surgeons to pick up clinically relevant cancers that were missed when using current visual detection methods. The best approach would be to use both techniques in tandem, according to the findings published today in European Urology.

The SmartTarget® software has been commercialised by SmartTarget Ltd, a company spun out by UCLB.

Read the full story here: UCL

2018-12-06T16:42:35+00:00